TNFSF10 and myeloid sarcoma: Several studies have searched for allelic variants associated with the response to IFN beta treatment in MS [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], but, to the best of our knowledge, none of them has deeply analysed the genes of TRAIL and its four membrane receptors with regards to this response.